Xiaolin Zi

Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin)

Yen‐Yu Lu, Xiaolin Zi, Yuqing Zhao et al. · JNCI Journal of the National Cancer Institute · 2001 · 889 citations · Full text

Medicine, Oncology, Pharmacology +15

Silibinin decreases prostate-specific antigen with cell growth inhibition via G ₁ arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention

Xiaolin Zi, Rajesh Agarwal · Proceedings of the National Academy of Sciences · 1999 · 237 citations · Full text

Medicine, Oncology, Pharmacology +17

Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration

Yi‐Chao Zheng, Ying‐Chao Duan, Jinlian Ma et al. · Journal of Medicinal Chemistry · 2013 · 219 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

Molecular mechanisms underlying IGF‐I‐induced attenuation of the growth‐inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells

Yuhong Lu, Xiaolin Zi, Michaël Pollak · International Journal of Cancer · 2003 · 205 citations · Full text

Medicine, Oncology, Pharmacology +17

Flavokawain A, a Novel Chalcone from Kava Extract, Induces Apoptosis in Bladder Cancer Cells by Involvement of Bax Protein-Dependent and Mitochondria-Dependent Apoptotic Pathway and Suppresses Tumor Growth in Mice

Xiaolin Zi, Anne R. Simoneau · Cancer Research · 2005 · 199 citations

Medicine, Oncology, Pharmacology +16